Stephen I. Deutsch

6.5k total citations
202 papers, 5.1k citations indexed

About

Stephen I. Deutsch is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Stephen I. Deutsch has authored 202 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Cellular and Molecular Neuroscience, 73 papers in Molecular Biology and 49 papers in Cognitive Neuroscience. Recurrent topics in Stephen I. Deutsch's work include Neuroscience and Neuropharmacology Research (61 papers), Receptor Mechanisms and Signaling (27 papers) and Autism Spectrum Disorder Research (26 papers). Stephen I. Deutsch is often cited by papers focused on Neuroscience and Neuropharmacology Research (61 papers), Receptor Mechanisms and Signaling (27 papers) and Autism Spectrum Disorder Research (26 papers). Stephen I. Deutsch collaborates with scholars based in United States, United Kingdom and Germany. Stephen I. Deutsch's co-authors include Richard B. Rosse, Barbara L. Schwartz, John Mastropaolo, Jessica A. Burket, Andrew D. Benson, John M. Morihisa, Maria R. Urbano, Amy L. Herndon, Ana Hitri and Tanya N. Alim and has published in prestigious journals such as American Journal of Psychiatry, Neurology and Biological Psychiatry.

In The Last Decade

Stephen I. Deutsch

199 papers receiving 4.9k citations

Peers

Countries citing papers authored by Stephen I. Deutsch

Since Specialization

Citations

This map shows the geographic impact of Stephen I. Deutsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen I. Deutsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen I. Deutsch more than expected).

Fields of papers citing papers by Stephen I. Deutsch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen I. Deutsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen I. Deutsch. The network helps show where Stephen I. Deutsch may publish in the future.

Co-authorship network of co-authors of Stephen I. Deutsch

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen I. Deutsch. A scholar is included among the top collaborators of Stephen I. Deutsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen I. Deutsch. Stephen I. Deutsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The 15q13.3 deletion syndrome: Deficient α7-containing nicotinic acetylcholine receptor-mediated neurotransmission in the pathogenesis of neurodevelopmental disorders 2015 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Stephen I. Deutsch, Jessica A. Burket, Andrew D. Benson, Maria R. Urbano	33
2	Targeting alpha-7 nicotinic neurotransmission in schizophrenia: A novel agonist strategy 2013 ·Schizophrenia Research ·Stephen I. Deutsch, Barbara L. Schwartz, Nina R. Schooler, C. Hendricks Brown, Richard B. Rosse, (unknown)	54
3	Poster Session II 2010 ·Neuropsychopharmacology ·Stephen I. Deutsch, Jessica A. Burket, Luis F. Jacome, William R. Cannon, Amy L. Herndon, Meredith A. Fox, (unknown), F. R. Hall	1
4	D-serine improves dimensions of the sociability deficit of the genetically-inbred Balb/c mouse strain 2010 ·Brain Research Bulletin ·Luis F. Jacome, Jessica A. Burket, Amy L. Herndon, William R. Cannon, Stephen I. Deutsch	28
5	An epigenetic intervention interacts with genetic strain differences to modulate the stress-induced reduction of flurazepam's antiseizure efficacy in the mouse 2009 ·European Neuropsychopharmacology ·Stephen I. Deutsch, John Mastropaolo, Jessica A. Burket, Richard B. Rosse	9
6	Mitochondrial Myopathy Complicated by Eating Disorder: A Case Report Highlighting the Potential Interaction of Genetic, Metabolic, and Psychodynamic Factors 2007 ·CNS Spectrums ·Stephen I. Deutsch, Richard B. Rosse, Mohammad A. Yaseen, (unknown), (unknown)	2
7	Faulty regulation of tau phosphorylation by the reelin signal transduction pathway is a potential mechanism of pathogenesis and therapeutic target in Alzheimer's disease 2006 ·European Neuropsychopharmacology ·Stephen I. Deutsch, Richard B. Rosse, Lynn H. Deutsch	12
8	Behavioral consequences of methyllycaconitine in mice: a model of α7 nicotinic acetylcholine receptor deficiency 2004 ·Life Sciences ·(unknown), John Mastropaolo, Richard B. Rosse, Alan S. Bellack, Stephen I. Deutsch	22
9	Nefazodone in the Adjunctive Therapy of Schizophrenia: An Open-Label Exploratory Study 2000 ·Clinical Neuropharmacology ·Paul B. Rosenberg, Richard B. Rosse, Barbara L. Schwartz, Stephen I. Deutsch	6
10	Visual scanning of faces correlates with schizophrenia symptomatology 1998 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Richard B. Rosse, Barbara L. Schwartz, (unknown), Stephen I. Deutsch	15
11	MK-801 alters the GABAA receptor complex and potentiates flurazepam's antiseizure efficacy 1995 ·Pharmacology Biochemistry and Behavior ·Stephen I. Deutsch, CHAN H. PARK, (unknown), (unknown), Lee Koetzner, John Mastropaolo	13
12	Measurement of an Explosive Behavior in the Mouse, Induced by MK-801, a PCP Analogue 1993 ·Clinical Neuropharmacology ·Stephen I. Deutsch, Ana Hitri	26
13	Discriminative stimulus properties of midazolam are shared by a GABA-receptor positive steroid 1993 ·Pharmacology Biochemistry and Behavior ·Stephen I. Deutsch, John Mastropaolo	19
14	Differentiation Between MK-801− and Apomorphine-Induced Stereotyped Behaviors in Mice 1993 ·Clinical Neuropharmacology ·Ana Hitri, David O’Connor, Joshua M. Cohen, (unknown), Stephen I. Deutsch	15
15	Clock drawing in the screening assessment of cognitive impairment in an ambulatory care setting: A preliminary report 1992 ·General Hospital Psychiatry ·(unknown), Richard B. Rosse, Barbara L. Schwartz, (unknown), Stephen I. Deutsch	45
16	Glycinergic interventions potentiate the ability of MK 801 to raise the threshold voltage for tonic hindlimb extension in mice 1992 ·Pharmacology Biochemistry and Behavior ·(unknown), John Mastropaolo, David O’Connor, (unknown), Stephen I. Deutsch	16
17	Two AI languages for simulation 1991 ·(unknown), Stephen I. Deutsch, (unknown)	2
18	Substance Use Diagnoses and Discharge Patterns Among Psychiatric Inpatients 1991 ·Psychiatric Services ·(unknown), Richard B. Rosse, Michael J. Sheridan, Stephen I. Deutsch	24
19	Glycine: A Possible Role in Lithium’s Action and Affective Illness 1983 ·Neuropsychobiology ·Stephen I. Deutsch, Michael Stanley, Eric D. Peselow, Miriam Banay‐Schwartz	6
20	Age of Onset of Affective Illness 1982 ·Psychopathology ·Eric D. Peselow, David L. Dünner, Ronald R. Fieve, Stephen I. Deutsch, Morton Rubinstein	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact